Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small‑Molecule API Manufacturing Capacity in Delaware
By Kieran
Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small‑Molecule API Manufacturing Capacity in Delaware
Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth
By tn_admin
Wilmington PharmaTech Appoints Industry Veteran Kent Payne as Managing Director and Board Member
By tn_admin
Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
By tn_admin